Repair Protein Mutations – Friday Pop Quiz 6/12
103481034810348Repair Protein Mutations A 35 year old female is found to have mismatch repair protein mutations and this finding. Which of the following is the next best step? A. Check BUN/Cr B. Check TSH/T4 C. Positron emission tomography D. Urinary cytology E. CT Head To find out the correct answer and read the explanation, click here. Brought to you by our brand partner Derm In-Review.  A product of SanovaWorks. …
Repair Protein Mutations
Platelet Rich Plasma: “The Process Is The Product”
103201032010320PRPPlatelet-rich plasma or PRP, derived from the patient’s own blood, is considered by many to be an all-natural, safe product with rejuvenation properties. Here, we discuss what exactly is PRP, the qualities that would make an ideal PRP extraction system, and the work that lies ahead to standardize current treatment protocols. Dr. Terrence Keaney led a lecture on platelet-rich plasma (PRP) at t …
PRP
JDD June Issue Highlights
103021030210302Here are the June JDD Issue Highlights: Guest Editor Dr. James Q. Del Rosso stresses that even the best case scenario of teledermatology can never offer the same as a live in-person visit in Virtual Exams No Substitute for In-Person Care of Acne and Rosacea. Treating Inflammation in Rosacea: Current Options and Unmet Needs, authors discuss the underlying inflammatory nature of rosacea, tre …
Clinical Trial – Friday Pop Quiz 6/5
102921029210292clinical trial The patient developed this cutaneous adverse event 2 weeks after starting a clinical trial medication. What is the mechanism of action of the culprit medication? A. Epidermal growth factor receptor (EGFR) inhibitor B. Tumor necrosis factor (TNF)-alpha inhibitor C. Smoothened inhibitor D. BRAF inhibitor E. Programmed cell death (PD)-1 inhibitor To find out the correct answer and …
clinical trial
Inhibiting the JAK/STAT Pathway to Treat Inflammatory Skin Diseases
102831028310283JAK InhibitorsNext Steps in Derm, in partnership with ODAC Dermatology, Aesthetic and Surgical Conference, interviewed Dr. Jonathan Zippin, Vice-Chair of Research and an Associate Attending Dermatologist and Associate Professor of Dermatology at Weill Medical College of Cornell, and Director of the Contact, Occupational and Photodermatitis Service. Watch as he reviews the JAK/STAT signaling pathway in normal i …
JAK Inhibitors